CLX: Leadership change · Company disclosure

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) On May 26, 2026, Linda Rendle, Chair of the Board of Directors (the “Board”) and Chief Executive Officer (“CEO”) of The Clorox Company (the “Company”), asked the Board to initiate a CEO search process, as she has made the decision to step down for health reasons. Ms. Rendle will remain as Chair and CEO while the search is conducted and until the new CEO is appointed. Ms. Rendle will also serve in an advisory role for a period following the appointment to drive business performance and a smooth leadership transition. Item 7.01 Regulation FD Disclosure. On May 28, 2026, the Company announced that the Board will initiate a comprehensive CEO search process, with Ms. Rendle to step down following the appointment of the new CEO. The full text of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. Item 9.01 Financial Statements and Exhibits (d) Exhibits See the Exhibit Index below. EXHIBIT INDEX Exhibit Description 99.1 Press Release dated May 28, 2026 of The Clorox Company 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CLOROX COMPANY Date: May 28, 2026 By: /s/ Angela Hilt Angela Hilt Executive Vice President - Chief Legal and External Affairs Officer & Corporate Secretary